» Articles » PMID: 36605429

Classification and Challenges in the Histopathological Diagnosis of Peripheral T-cell Lymphomas, Emphasis on the WHO-HAEM5 Updates

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Jan 6
PMID 36605429
Authors
Affiliations
Soon will be listed here.
Abstract

Mature T-cell lymphomas represent neoplastic expansions of T-cell lymphocytes with a post-thymic derivation. Most of these tumors feature aggressive clinical behavior and challenging histopathological diagnosis and classification. Novel findings in the genomic landscape of T-cell lymphomas are helping to improve the understanding of the biology and the molecular mechanisms that underly its clinical behavior. The most recent WHO-HAEM5 classification of hematolymphoid tumors introduced novel molecular and histopathological findings that will aid in the diagnostic classification of this group of neoplasms. The current review article summarizes the most relevant diagnostic features of peripheral T-cell lymphomas with an emphasis on the updates that are incorporated at the WHO-HAEM5.

Citing Articles

Prognostic and clinicopathological value of soluble programmed cell death ligand-1 (sPD-L1) in patients with peripheral T-cell lymphoma: a meta-analysis.

Wu Y, Zhang Y Ann Med. 2025; 57(1):2458236.

PMID: 39928126 PMC: 11812115. DOI: 10.1080/07853890.2025.2458236.


Intestinal T-cell lymphomas NOS presenting as a polypoidal lesion: A case report.

Bi H, Bai J, Wang L, Liang C, Wu Y Medicine (Baltimore). 2024; 103(23):e38465.

PMID: 38847694 PMC: 11155561. DOI: 10.1097/MD.0000000000038465.


Cutaneous Intravascular Hematolymphoid Entities: A Review.

Marshall E, Brumbaugh B, Holt A, Chen S, Hoang M Diagnostics (Basel). 2024; 14(7).

PMID: 38611591 PMC: 11011375. DOI: 10.3390/diagnostics14070679.


Therapeutic challenges in peripheral T-cell lymphoma.

Luan Y, Li X, Luan Y, Luo J, Dong Q, Ye S Mol Cancer. 2024; 23(1):2.

PMID: 38178117 PMC: 10765866. DOI: 10.1186/s12943-023-01904-w.


SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target.

Carty S, Murga-Zamalloa C, Wilcox R Clin Lymphoma Myeloma Leuk. 2023; 23(8):561-574.

PMID: 37142534 PMC: 10565700. DOI: 10.1016/j.clml.2023.04.007.

References
1.
Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S . Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol. 2004; 24(5):1165-74. View

2.
Tabanelli V, Corsini C, Fiori S, Agostinelli C, Calleri A, Orecchioni S . Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas. Hum Pathol. 2019; 90:60-69. DOI: 10.1016/j.humpath.2019.05.007. View

3.
Foss F, Horwitz S, Civallero M, Bellei M, Marcheselli L, Kim W . Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas. Am J Hematol. 2019; 95(2):151-155. PMC: 8025136. DOI: 10.1002/ajh.25674. View

4.
Sieniawski M, Angamuthu N, Boyd K, Chasty R, Davies J, Forsyth P . Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood. 2010; 115(18):3664-70. DOI: 10.1182/blood-2009-07-231324. View

5.
Ng S, Lai K, Murugaya S, Lee K, Loong S, Fook-Chong S . Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004; 17(9):1097-107. DOI: 10.1038/modpathol.3800157. View